# EDGAR Filing Document

**Accession Number:** 0001285785
**File Stem:** 0001628280-25-048961
**Filing Date:** 2025-11
**Character Count:** 109177
**Document Hash:** 747b5f3b45204248ed29a777688098d7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-048961.hdr.sgml**: 20251104

**ACCESSION NUMBER**: 0001628280-25-048961

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20250930

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251104

**DATE AS OF CHANGE**: 20251104

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MOSAIC CO
- **CENTRAL INDEX KEY:** 0001285785
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE CHEMICALS [2870]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 201026454
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-32327
- **FILM NUMBER:** 251450470

**BUSINESS ADDRESS:**
- **STREET 1:** 101 EAST KENNEDY BLVD.
- **STREET 2:** SUITE 2500
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33602
- **BUSINESS PHONE:** 813-775-4200

**MAIL ADDRESS:**
- **STREET 1:** 101 EAST KENNEDY BLVD.
- **STREET 2:** SUITE 2500
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33602

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GLOBAL NUTRITION SOLUTIONS INC
- **DATE OF NAME CHANGE:** 20040401

?xml version='1.0' encoding='ASCII'? mos-20251104

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM 8-K** 

**CURRENT REPORT** 

**Pursuant to Section 13 or 15(d) of the** 

**Securities Exchange Act of 1934** 

**Date of Report (Date of earliest event reported): November 4, 2025** 

**THE MOSAIC COMPANY** 

**(Exact name of registrant as specified in its charter)** 

---

| | | |
|:---|:---|:---|
| **DE** | **001-32327** | **20-1026454** |
| **(State or other jurisdiction**<br>**of incorporation)** | **(Commission**<br>**File Number)** | **(IRS Employer**<br>**Identification No.)** |

---

---

| | | |
|:---|:---|:---|
| **101 East Kennedy Blvd.** | **101 East Kennedy Blvd.** | **33602** |
| **Suite 2500** | **Suite 2500** | **33602** |
| **Tampa,** | **Florida** | **33602** |
| **(Address of principal executive offices)** | **(Address of principal executive offices)** | **(Zip Code)** |

---

**Registrant's telephone number, including area code: (800) 918-8270** 

**Not applicable** 

**(Former Name or Former Address, if Changed Since Last Report)** 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

---

| | | | |
|:---|:---|:---|:---|
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Securities registered pursuant to Section 12(b) of the Act | Securities registered pursuant to Section 12(b) of the Act | Securities registered pursuant to Section 12(b) of the Act | Securities registered pursuant to Section 12(b) of the Act |
| Title of each class | Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.01 per share | Common Stock, par value $0.01 per share | MOS | New York Stock Exchange |
| Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. | Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. | Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. | Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. |
| ☐ | Emerging growth company | | |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻ |

---

------

---

| | |
|:---|:---|
| **Item 2.02.** | **Results of Operations and Financial Condition.** |

---

The following information is being "furnished" in accordance with General Instruction B.2. of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such filing:

Furnished herewith as Exhibit 99.1 and incorporated by reference herein is the text of The Mosaic Company's ("Mosaic," and Mosaic and its subsidiaries, individually or in any combination, "we," "us" or "our") announcement regarding its earnings and results of operations for the quarter ended September 30, 2025, as presented in a press release issued on November 4, 2025.

Furnished herewith as Exhibit 99.2 and incorporated by reference herein is certain performance data for the period ended September 30, 2025 to be published on Mosaic's website.

---

| | |
|:---|:---|
| **Item 9.01.** | **Financial Statements and Exhibits.** |

---

(d) Exhibits.

Reference is made to the Exhibit Index hereto with respect to the exhibits furnished herewith. The following exhibits are being "furnished" in accordance with General Instruction B.2. of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall they be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 99.1 | <u>[Press release, dated](pressreleaseq32025-ex991.htm)[November 4](pressreleaseq32025-ex991.htm)[, 2025, of The Mosaic Company regarding its earnings and results of operations for the quarter ended](pressreleaseq32025-ex991.htm)[Sept](pressreleaseq32025-ex991.htm)[ember](pressreleaseq32025-ex991.htm)[30, 2025](pressreleaseq32025-ex991.htm)</u> |
| 99.2 | <u>[Performance data for the period ended](performancedataq32025-ex992.htm)[Se](performancedataq32025-ex992.htm)[ptember](performancedataq32025-ex992.htm)[30, 2025](performancedataq32025-ex992.htm)</u> |
| 104 | Cover Page Interactive Data File, formatted in Inline XBRL |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **THE MOSAIC COMPANY** | **THE MOSAIC COMPANY** |
| Date: November 4, 2025 | By: | /s/ Philip E. Bauer |
|  | Name: | Philip E. Bauer |
|  | Title: | Senior Vice President, General Counsel |
|  |  | and Corporate Secretary |

---

## Exhibit 99.1

**Exhibit 99.1**

---

| | |
|:---|:---|
| ![image1a31.jpg](image1a31.jpg) | **The Mosaic Company**<br>101 E. Kennedy Blvd., Suite 2500<br>Tampa, FL 33602<br>www.mosaicco.com |

---

---

| | | |
|:---|:---|:---|
| **FOR IMMEDIATE RELEASE** | | |
| **<u>Investors</u>**<br>Joan Tong, CFA<br>863-640-0826<br>joan.tong@mosaicco.com | Jason Tremblay<br>813-775-4282<br>jason.tremblay@mosaicco.com | **<u>Media</u>**<br>Ben Pratt<br>813-775-4206<br>benjamin.pratt@mosaicco.com |

---

**THE MOSAIC COMPANY REPORTS THIRD QUARTER 2025 RESULTS**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Net income of $411 million and adjusted EBITDA***<sup>(1)</sup> ***of $806 million in the third quarter of 2025***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Third quarter phosphate production volumes of 1.7 million tonnes mark the third consecutive quarter of improvement. Production volumes for the trailing three-month period ending in October totaled approximately 1.8 million tonnes***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Potash production volumes trending toward record level in 2025***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• ***Mosaic Fertilizantes' performance remains strong; operating income of $96 million increased 71% and adjusted EBITDA***<sup>(1)</sup> ***at $241 million increased 190% versus the prior year quarter***

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***• Completion of the Patos de Minas and Taquari transactions following the close of the quarter generated $63 million in immediate aggregate proceeds***

TAMPA, FL, November 4, 2025 - The Mosaic Company (NYSE: MOS), reported net income of $411 million and diluted earnings per share (EPS) of $1.29 for the third quarter of 2025. Adjusted EBITDA<sup>(1)</sup> was $806 million and adjusted EPS<sup>(1)</sup> was $1.04 for the quarter.

"Mosaic generated strong earnings despite operational and market challenges in the third quarter," said President and CEO Bruce Bodine. "Our business in Brazil continued to perform well while navigating the ongoing credit issues in Brazilian agriculture, and we delivered solid performance in our potash business, as strong global demand pushed prices higher. In phosphates, our work to restore asset health has led to three consecutive months of higher production, and now we are focused on driving further improvements and sustainably higher operating rates. With global market access as a strategic advantage, we have the ability to capitalize on constructive agricultural and fertilizer market trends and adapt to shifting market dynamics."

<sup>(1)</sup> See "Non-GAAP Financial Measures" for additional information and reconciliation.

<sup>(2)</sup> See "Notable Items Listing" for additional information.

------

**Consolidated Results:** 

---

| | | | |
|:---|:---|:---|:---|
| *In millions $ except as noted below* | **Q3 2025** | **Q2 2025** | **Q3 2024** |
| Net Sales *(Billions)* | $3.5 | $3.0 | $2.8 |
| Selling, General and Administrative Expenses | $126 | $167 | $148 |
| Operating Earnings  | $340 | $244 | $115 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating Earnings – Phosphate | $102 | $(8) | $8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating Earnings – Potash | $229 | $194 | $109 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating Earnings – Mosaic Fertilizantes | $96 | $109 | $56 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating Earnings (Loss) – Corporate and Other | $(88) | $(51) | $(58) |
| Net Income | $411 | $411 | $122 |
| Adjusted EBITDA<sup>(1)</sup> | $806 | $566 | $448 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA - Phosphate<sup>(1)</sup> | $280 | $217 | $265 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA - Potash<sup>(1)</sup> | $329 | $278 | $180 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA – Mosaic Fertilizantes<sup>(1)</sup> | $241 | $159 | $83 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA – Corporate and Other<sup>(1)</sup> | $(44) | $(88) | $(80) |

---

Net income of $411 million in the third quarter of 2025 was positively impacted by notable items totaling $135 million, pre-tax, mainly due to a $308 million mark-to-market unrealized gain on the value of the Ma'aden shares (worth approximately $1.9 billion USD at the end of third quarter) partially offset by $173 million of losses driven by a $75 million loss on the treatment of our Taquari mine as an asset held for sale.

Adjusted EBITDA<sup>(1)</sup> of $806 million in the third quarter of 2025 increased by 80% from the prior year and was driven primarily by the continued outperformance of Mosaic Fertilizantes, and a significant increase in phosphate stripping margins and higher potash prices versus the prior year.

Third quarter selling, general and administrative (SG&A) expense was $126 million, down from $167 million in the second quarter, and from $148 million in the same quarter of the prior year primarily driven by bad debt expenses reported in each of the comparative periods.

The effective tax rate for the third quarter of 2025 was 29.3%. The adjusted effective tax rate was 25.9% excluding one-time net favorable impacts from notable tax items. Cash taxes paid were $89 million. See the table included in the non-GAAP financial measures section of this press release for a reconciliation of the adjusted effective tax rate.

Cash flow from operations was $229 million in the third quarter of 2025 versus $313 million in the same quarter of the prior year, a reduction driven primarily by higher working capital as a result of timing of shipments, higher prices and volumes of product inventories in Brazil, and higher inventories of phosphate rock to support future production plans. Assuming the reversal of these effects, cash flow from operations is expected to improve in the fourth quarter. Capital expenditures for the third quarter were $364 million up from $241 million in the same quarter of the prior year due to higher sustaining capex in Phosphate. Free cash flow<sup>(1)</sup> in the third quarter of 2025 was $(135) million compared to $72 million in the same quarter last year.

In October, Mosaic completed the sale of the Patos de Minas mine for $111 million, with $51 million collected at closing and the remaining proceeds to be received over four years.

In November, Mosaic completed the sale of its Taquari potash mine for $27 million. The transaction is expected to eliminate capital investments exceeding $25 million and asset retirement obligations of $22 million.

<sup>(1)</sup> See "Non-GAAP Financial Measures" for additional information and reconciliation.

------

Mosaic continues to engage with interested parties to advance strategic alternatives for its Carlsbad, New Mexico potash mine. In Brazil, Mosaic expects to complete the studies to better define the Niobium opportunity at the Patrocinio and Araxa phosphate operations early next year and to reengage interested parties to discuss strategic alternatives in the first half of 2026.

Mosaic paid a $0.22 per share dividend in the third quarter, equivalent to $70 million returned to shareholders.

**Potash Results and Outlook:**

---

| | | | |
|:---|:---|:---|:---|
| *In millions $ except as noted below* | **Q3 2025** | **Q2 2025** | **Q3 2024** |
| Net Sales | $695 | $711 | $526 |
| Sales Volumes million tonnes\* | 2.3 | 2.3 | 2.0 |
| MOP Selling Price FOB mine | $271 | $261 | $215 |
| MOP Cash Cost of Production per tonne<sup>(1)</sup> | $71 | $75 | $74 |
| Gross Margin per tonne | $104 | $89 | $61 |
| Operating Earnings | $229 | $194 | $109 |
| Segment Adjusted EBITDA<sup>(1)</sup> - millions | $329 | $278 | $180 |

---

\*Tonnes = finished product tonnes

The Potash segment reported net sales of $695 million in the third quarter of 2025, up from $526 million in the same quarter of the prior year. Operating earnings were $229 million, up from $109 million in the same quarter of the prior year. Adjusted EBITDA<sup>(1)</sup> was $329 million, compared to $180 million in the same quarter of 2024, reflecting higher sales volume and market prices for potash.

Higher production levels drove MOP cash cost of production per tonne<sup>(1)</sup> down to $71 in the third quarter, from $74 a year ago, despite continued operations of the high cost Colonsay mine. Idle and turnaround expenses declined to $16 million in the third quarter, from $34 million in the second quarter, reflecting the completion of planned turnaround activities at Esterhazy.

Given the potential demand deferral in North America, Mosaic expects 2025 potash production volumes to be in the range of 9.1 to 9.4 million tonnes.

Sales volumes in the fourth quarter are expected to be between 2.3 and 2.6 million tonnes, with realized mine gate MOP prices in the range of $270 to $280 per tonne.

**Phosphate Results and Outlook:**

---

| | | | |
|:---|:---|:---|:---|
| *In millions $ except as noted below* | **Q3 2025** | **Q2 2025** | **Q3 2024** |
| Net Sales *(Billions)*  | $1.3 | $1.2 | $1.0 |
| Sales Volumes million tonnes\* | 1.6 | 1.5 | 1.5 |
| DAP Selling Price FOB plant | $714 | $668 | $569 |
| Phosphate Cash Cost of Conversion per tonne<sup>(1)</sup> | $131 | $126 | $101 |
| Blended Rock Cost Consumed in COGS per tonne | $80 | $74 | $87 |
| Gross Margin per tonne | $92 | $67 | $96 |
| Operating Earnings | $102 | $(8) | $8 |
| Segment Adjusted EBITDA<sup>(1)</sup> | $280 | $217 | $265 |

---

\*Tonnes = finished product tonnes

<sup>(1)</sup> See "Non-GAAP Financial Measures" for additional information and reconciliation.

------

Net sales in the Phosphate segment were $1.3 billion in the third quarter of 2025, up from $1.0 billion in the third quarter of 2024, reflecting higher sales volumes and prices. Phosphate operating earnings were $102 million, compared to $8 million a year ago. Adjusted EBITDA<sup>(1)</sup> totaled $280 million in the third quarter of 2025, an increase from $265 million in the third quarter of 2024, reflecting higher stripping margins and lower sales volumes in the prior year due to hurricane impacts.

Production volumes totaled 1.7 million tonnes in the third quarter of 2025. Previously reported issues that occurred at the Bartow and Riverview facilities have been addressed. For the trailing three-month period ending in October, production output reached approximately 1.8 million tonnes. Mosaic expects production volumes to continue to improve and sustain at higher operating rates.

As expected, third quarter idle and turnaround expenses declined to $42 million, from $84 million in the second quarter of 2025. However, Mosaic incurred considerable costs associated with asset health initiatives primarily during July. Consequently, cash cost of conversion per tonne<sup>(1)</sup> was $131 in the third quarter, up from $101 in the prior year quarter, and from $126 in the second quarter. For the fourth quarter, Mosaic expects this metric to decline sequentially, driven by expected normalized repair cost levels, increased production volumes and improved fixed cost absorption.

Sales volumes were 1.6 million tonnes in the third quarter of 2025, below production volumes, caused by lags in shipments to customers due to delivery timing.

For the fourth quarter of 2025, sales volumes are expected to be 1.7 to 1.9 million tonnes, though some demand could be deferred from winter fill to spring in North America. DAP prices on an FOB basis are expected to average in the $700 to $730 per tonne range.

**Mosaic Fertilizantes Results and Outlook:**

---

| | | | |
|:---|:---|:---|:---|
| *In millions $ except as noted below* | **Q3 2025** | **Q2 2025** | **Q3 2024** |
| Net Sales *(Billions)*  | $1.6 | $1.2 | $1.4 |
| Sales Volumes million tonnes\* | 2.8 | 2.2 | 2.9 |
| Sales Volumes of produced product – million tonnes<sup>(3)</sup>  | 1.0 | 1.1 | 1.0 |
| Average Finished Product Selling Price | $518 | $474 | $447 |
| Phosphate Cash Cost of Conversion per tonne<sup>(1)</sup> | $99 | $84 | $88 |
| Phosphate Blended Rock Cost Consumed in COGS per tonne | $99 | $94 | $105 |
| Gross Margin per tonne | $65 | $73 | $44 |
| Operating Earnings | $96 | $109 | $56 |
| Segment Adjusted EBITDA<sup>(1)</sup>  | $241 | $159 | $83 |

---

\*Tonnes = finished product tonnes sold to third parties

<sup>(3)</sup> Represents volumes produced in Brazil and sold directly to third parties or through distribution

Mosaic Fertilizantes reported net sales of $1.6 billion in the third quarter of 2025, up from $1.4 billion in the third quarter of 2024, driven by higher prices, partially offset by slightly lower sales volumes. Mosaic Fertilizantes operating earnings were $96 million, up from $56 million a year ago. Adjusted EBITDA<sup>(1)</sup> totaled $241 million in the third quarter of 2025, up from $83 million in the same quarter of prior year. Mosaic reported gross margin per tonne of $65 in the third quarter of 2025, compared to $44 in the third quarter of 2024, primarily driven by higher prices, offset by lower distribution profitability as credit issues continued and market conditions have softened.

<sup>(1)</sup> See "Non-GAAP Financial Measures" for additional information and reconciliation.

------

Mosaic Fertilizantes phosphate cash cost of conversion per tonne<sup>(1)</sup> in the third quarter of 2025 was $99, which increased from $88 in the same quarter prior year, primarily impacted by product mix, maintenance activities, and strengthening of Brazilian Real. Phosphate blended rock cost per tonne decreased to $99 in the third quarter of 2025, from $105 in the same period prior year due to higher volumes as well as reduced usage of higher cost imported rock despite negative FX impacts.

Mosaic Fertilzantes sales volumes of 2.8 million tonnes in the third quarter decreased slightly from a year ago, primarily driven by softer-than-expected fertilizer shipments during the soybean application season amid a challenging credit environment. Mosaic continues to adopt prudent business and risk management practices and prioritize sales to customers with strong credit profiles. Notably, Mosaic recovered $27 million of prior bad debt expense and recorded no material new bad debt expense in the third quarter. Looking ahead, Mosaic expects 2025 sales volumes to be in the range of 9.4 to 9.6 million tonnes.

Fourth quarter sales volumes are expected to be slightly below the third quarter, driven by normal seasonality. Distribution margin per tonne is expected to be below the normal annualized $30-$40 range, also reflecting typical seasonality. Production margin is expected to be lower than the third quarter due to lower selling prices and higher raw material costs. As a result, fourth quarter segment adjusted EBITDA is expected to be approximately $100 million given the downside risk related to continuing credit constraints.

**Mosaic Biosciences Update**

Mosaic Biosciences product sales more than doubled in the first nine months of 2025 compared with the same period of 2024. Year to date, Mosaic Biosciences has launched 4 new products<sup>(5)</sup> and remains on track to launch an additional product in 2025. Sales are expected to more than double to about $70 million in 2025, and Mosaic Biosciences is expected to positively contribute to adjusted EBITDA in the fourth quarter.

**Agriculture Market and Macroeconomic Update** 

Ag economics are dynamic around the globe. Trade uncertainty has impacted near-term sentiment in North America, but recent improvement in commodity prices should encourage more fertilizer activity. In Brazil, growers have had to navigate lower commodity prices and tighter credit availability, yet our customers are actively buying fertilizer for upcoming seasons. Ag economics remain more constructive in other parts of the world, including key Canpotex markets. Canpotex is expected to set a shipment record this year given strong demand in its geographies.

**Plant Nutrient Market Update** 

Fertilizer markets have remained balanced to tight for much of the year, which has supported prices. Recent price activity has improved affordability and is expected to encourage market engagement to replenish significant nutrient tonnes removed during recent large harvests.

Phosphate supply and demand fundamentals remain constructive: Growing demand for phosphate fertilizer, more demand from the industrial sector for LFP batteries, limited new capacity expected in the medium-term, and reduced Chinese exports continue to create tight markets. Chinese phosphate fertilizer exports are expected to fall more than 1.5 million tonnes this year, and China has recently pulled back phosphate export approvals, which will tighten the market heading into 2026.

Potash markets are balanced after a first-half supply deficit. Global demand has been steady and is expected to test another record as affordability has encouraged robust Chinese consumption, strong Brazilian imports, and growing Southeast Asian demand. We expect record Canpotex shipments this year and further strength into 2026. North American demand has held relatively consistent this year, though with current crop prices and trade uncertainty, we could see modest demand deferral this fall.

<sup>(1)</sup> See "Non-GAAP Financial Measures" for additional information and reconciliation.

<sup>(5)</sup> New products are defined as new brands or existing brands launched in new geographies

------

**2025 Guidance Summary**

---

| | |
|:---|:---|
| | **Full Year 2025** |
| Phosphate Production Volumes (million tonnes) | 6.3 - 6.5 |
| Potash Production Volumes (million tonnes) | 9.1 - 9.4 |
| Mosaic Fertilizantes Sales Volumes (million tonnes) | 9.4 - 9.6 |
| Total Capital Expenditures | Approx. $1.3 billion |
| Depreciation, Depletion & Amortization | $1.1 - $1.2 billion |
| Selling, General, and Administrative Expense | $530 - $550 million |
| Net Interest Expense | $180 - $200 million |
| Effective tax rate | High 20's % |
| Cash tax rate | Low 20's % |

---

---

| | |
|:---|:---|
| | **Fourth Quarter 2025** |
| Phosphate Sales Volumes (million tonnes) | 1.7 - 1.9 |
| DAP FOB Plant Prices | $700 - $730 |
| Potash Sales Volumes (million tonnes) | 2.3 - 2.6 |
| MOP FOB Mine Prices | $270 - $280 |

---

**Sensitivities Table** 

The Company provided the following sensitivities using 2024 cost structure to price and foreign exchange rates to help investors anticipate the potential impact of movements in these factors.

---

| | | |
|:---|:---|:---|
| **Sensitivity** | **Full year adj. EBITDA impact**<sup>(1)</sup> | **2024 Actual** |
| Average MOP Price / tonne (fob mine) | $10/mt price change = $58 million <sup>(4)</sup> | $222 |
| Average DAP Price / tonne (fob plant) | $10/mt price change = $64 million | $585 |

---

<sup>(1)</sup> See "Non-GAAP Financial Measures" for additional information and reconciliation.

<sup>(4)</sup> Includes impact of Canadian Resource Tax

**About The Mosaic Company**

The Mosaic Company is one of the world's leading producers and marketers of concentrated phosphate and potash crop nutrients. Through its Mosaic Biosciences platform, the company is also advancing the next generation biological solutions to help farmers improve nutrient use efficiency and crop performance sustainably. Mosaic provides a single-source supply of phosphate, potash, and biological products for the global agriculture industry. More information on the company is available at www.mosaicco.com.

Mosaic will conduct a conference call on November 5, 2025, at 11:00 a.m. Eastern Time to discuss third quarter 2025 earnings results. A simultaneous webcast of the conference call may be accessed through Mosaic's website at www.mosaicco.com/investors. This webcast will be available up to one year from the time of the earnings call.

*This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may include, but are not limited to, statements about future transactions or strategic plans and other statements about future financial and operating results. Such statements are based upon the current beliefs and expectations of The Mosaic Company's management and are subject to significant risks and uncertainties. These risks and uncertainties include, but are not limited to: political and economic instability and changes in government policies in countries in which we have operations; the predictability and volatility of, and customer expectations about, agriculture, fertilizer, raw material, energy and transportation markets that are subject to competitive and other pressures and economic and credit market conditions; the level of inventories in the distribution channels for crop nutrients; the effect of future product innovations or development of new technologies on demand for our products; changes in foreign currency and exchange rates; international trade risks, including the impact of U.S.* 

------

*tariffs and retaliatory tariffs on economic conditions; and other risks associated with Mosaic's international operations; a material adverse change in our Ma'aden investment with respect to the financial position, performance, operations or prospects of Ma'aden; customer defaults; the effects of Mosaic's decisions to exit business operations or locations; changes in government policy; changes in environmental and other governmental regulation, including expansion of the types and extent of water resources regulated under federal law, carbon taxes or other greenhouse gas regulation, implementation of numeric water quality standards for the discharge of nutrients into Florida waterways or efforts to reduce the flow of excess nutrients into the Mississippi River basin, the Gulf of America or elsewhere; further developments in judicial or administrative proceedings, or complaints that Mosaic's operations are adversely impacting nearby farms, business operations or properties; difficulties or delays in receiving, increased costs of or challenges to necessary governmental permits or approvals or increased financial assurance requirements; resolution of global tax audit activity; the effectiveness of Mosaic's processes for managing its strategic priorities; adverse weather conditions affecting operations in Central Florida, the Mississippi River basin, the Gulf Coast of the United States, Canada or Brazil, and including potential hurricanes, excess heat, cold, snow, rainfall or drought; actual costs of various items differing from management's current estimates, including, among others, asset retirement, environmental remediation, reclamation or other environmental regulation, Canadian resources taxes and royalties, reduction of Mosaic's available cash and liquidity, and increased leverage, due to its use of cash and/or available debt capacity to fund financial assurance requirements and strategic investments; brine inflows at Mosaic's potash mines; other accidents and disruptions involving Mosaic's operations, including potential mine fires, floods, explosions, seismic events, sinkholes or releases of hazardous or volatile chemicals; and risks associated with cyber security, including reputational loss; as well as other risks and uncertainties reported from time to time in The Mosaic Company's reports filed with the Securities and Exchange Commission. Actual results may differ from those set forth in the forward-looking statements.* 

***Non-GAAP Financial Measures***

*This press release includes the presentation and discussion of non-GAAP diluted net earnings per share, or adjusted EPS, non-GAAP adjusted EBITDA, non-GAAP cash cost of conversion or production per tonne, or non-GAAP adjusted effective tax rate, collectively referred to as non-GAAP financial measures. Generally, a non-GAAP financial measure is a supplemental numerical measure of a company's performance, financial position or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with U.S. generally accepted accounting principles, or GAAP. Non-GAAP financial measures should not be considered as substitutes for, or superior to, measures of financial performance prepared in accordance with GAAP. In addition, because non-GAAP measures are not determined in accordance with GAAP, they are thus susceptible to varying interpretations and calculations and may not be comparable to other similarly titled measures of other companies. Adjusted metrics, including adjusted EPS, adjusted gross margin, and adjusted EBITDA are calculated by excluding the impact of notable items from the GAAP measure. Notable items impact on gross margin and adjusted EBITDA is pretax. Notable items impact on diluted net earnings per share is calculated as the notable item amount plus income tax effect, based on expected annual effective tax rate, divided by diluted weighted average shares. Management believes that these adjusted measures provide securities analysts, investors, management and others with useful supplemental information regarding our performance by excluding certain items that may not be indicative of, or are unrelated to, our core operating results. Management utilizes these adjusted measures in analyzing and assessing Mosaic's overall performance and financial trends, for financial and operating decision-making, and to forecast and plan for future periods. These adjusted measures also assist our management in comparing our and our competitors' operating results. We are not providing forward looking guidance for U.S. GAAP reported diluted net earnings per share, gross margin per tonne, or a quantitative reconciliation of forward-looking adjusted EPS, adjusted gross margin and adjusted EBITDA because we are unable to predict with reasonable certainty our notable items without unreasonable effort. Historically, our notable items have included, but are not limited to, foreign currency transaction gain or loss, unrealized gain or loss on derivatives and equity securities, acquisition-related fees, discrete tax items, contingencies and certain other gains or losses. These items are uncertain, depend on various factors, and could have a material impact on U.S. GAAP reported results for the guidance period. Reconciliations for Non-GAAP financial measures contained in this press release are found below. Reconciliations for current and historical periods beginning with the quarter ended December 31, 2023 for consolidated adjusted EPS and adjusted EBITDA, as well as segment adjusted EBITDA and adjusted gross margin per tonne are provided in the Selected Calendar Quarter Financial Information performance data for the related periods. This information is being furnished under Exhibit 99.2 of the Form 8-K and available on our website at www.mosaicco.com in the "Financial Information - Quarterly Earnings" section under the "Investors" tab.*

------

For the three months ended September 30, 2025, the company reported the following notable items which, combined, positively impacted earnings per share by $0.25:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|<br>**Description** |<br>**Segment** |<br>**Line item** | **Amount**<br>**(in millions)** | **Tax effect**<br>**(in millions)** | **EPS impact**<br>**(per share)** |
| Foreign currency transaction gain (loss) | Consolidated | Foreign currency transaction gain (loss) | $(14) | $3 | $(0.04) |
| Unrealized gain (loss) on derivatives | Corporate and Other | Cost of goods sold | (27) | 7 | (0.06) |
| Closed and indefinitely idled facility costs | Phosphate | Other operating income (expense) | (14) | 3 | (0.03) |
| Ma'aden mark-to-market | Corporate and Other | Other non-operating income (expense) | 308 | (80) | 0.71 |
| Environmental Reserve | Phosphate | Other operating income (expense) | (18) | 5 | (0.04) |
| Loss on assets held for sale and transaction fees | Mosaic Fertilizantes/Corporate | Other operating income (expense)/SG&A | (75) |  | (0.23) |
| Asset write-off | Mosaic Fertilizantes | Cost of goods sold/Other operating income (expense) | (11) | 3 | (0.03) |
| Land reclamation | Phosphate | Cost of goods sold | (14) | 4 | (0.03) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total Notable Items |  |  | $135 | $(55) | $0.25 |

---

For the three months ended September 30, 2024, the company reported the following notable items which, combined, positively impacted earnings per share by $0.04:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|<br>**Description** |<br>**Segment** |<br>**Line item** | **Amount**<br>**(in millions)** | **Tax effect**<br>**(in millions)** | **EPS impact**<br>**(per share)** |
| Foreign currency transaction gain (loss) | Consolidated | Foreign currency transaction gain (loss) | $111 | $(35) | $0.22 |
| Unrealized gain (loss) on derivatives | Corporate and Other | Cost of goods sold | 38 | (11) | 0.09 |
| Closed and indefinitely idled facility costs | Phosphate | Other operating income (expense) | (15) | 5 | (0.03) |
| FX functional currency | Mosaic Fertilizantes | Cost of goods sold | 6 | (2) | 0.01 |
| Realized gain (loss) on RCRA Trust Securities | Phosphate | Other non-operating income (expense) | 5 | (2) | 0.01 |
| ARO Adjustment | Phosphate | Other operating income (expense) | (102) | 31 | (0.22) |
| Environmental reserve | Phosphate | Other operating income (expense) | (20) | 6 | (0.04) |
| &nbsp;&nbsp;&nbsp;Total Notable Items |  |  | $23 | $(8) | $0.04 |

---

------

**Condensed Consolidated Statements of Earnings** 

**(in millions, except per share amounts)**

---

| | |
|:---|:---|
| **The Mosaic Company** | **(unaudited)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Nine months ended** | **Nine months ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Net sales | $3452.1 | $2810.9 | $9078.7 | $8306.9 |
| Cost of goods sold | 2899.8 | 2394.1 | 7519.4 | 7096.9 |
| Gross margin | 552.3 | 416.8 | 1559.3 | 1210.0 |
| Selling, general and administrative expenses | 125.5 | 148.2 | 415.3 | 383.4 |
| Other operating expense | 87.0 | 153.2 | 221.3 | 305.0 |
| Operating earnings | 339.8 | 115.4 | 922.7 | 521.6 |
| Interest expense, net | (45.6) | (41.7) | (139.3) | (136.1) |
| Foreign currency transaction gain (loss) | (1.2) | 100.9 | 301.3 | (267.3) |
| Other income (expense) | 306.3 | (0.4) | 391.7 | 6.8 |
| Earnings from consolidated companies before income taxes | 599.3 | 174.2 | 1476.4 | 125.0 |
| Provision for income taxes | 175.5 | 48.0 | 384.8 | 152.9 |
| Earnings (loss) from consolidated companies | 423.8 | 126.2 | 1091.6 | (27.9) |
| Equity in net earnings of nonconsolidated companies | 0.3 | 4.5 | 2.2 | 64.2 |
| Net earnings including noncontrolling interests | 424.1 | 130.7 | 1093.8 | 36.3 |
| Less: Net earnings attributable to noncontrolling interests | 12.7 | 8.5 | 33.6 | 30.4 |
| Net earnings attributable to Mosaic | $411.4 | $122.2 | $1060.2 | $5.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted net earnings per share attributable to Mosaic | $1.29 | $0.38 | $3.33 | $0.02 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted weighted average number of shares outstanding | 319.4 | 319.4 | 318.8 | 321.6 |

---

------

**Condensed Consolidated Balance Sheets**

**(in millions, except per share amounts)**

---

| | |
|:---|:---|
| **The Mosaic Company** | **(unaudited)** |

---

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| **Assets** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $153.3 | $272.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivables, net, including affiliate receivables of $113.9 and $109.9, respectively | 1060.4 | 1113.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 3279.1 | 2548.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 583.0 | 563.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 5075.8 | 4498.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Property, plant and equipment, net of accumulated depreciation of $11,385.1 and $10,499.7, respectively | 13996.9 | 13352.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity securities and investments in nonconsolidated companies | 1940.8 | 1533.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill | 1091.8 | 1061.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | 1018.0 | 958.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other assets | 1544.2 | 1520.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $24667.5 | $22924.0 |
| **Liabilities and Equity** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term debt | $1153.7 | $847.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current maturities of long-term debt | 42.6 | 45.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Structured accounts payable arrangements | 402.5 | 402.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable, including affiliate payables of $214.7 and $155.1, respectively | 1215.0 | 1156.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 1635.9 | 1720.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 4449.7 | 4171.3 |
| Long-term debt, less current maturities | 3372.0 | 3332.3 |
| Deferred income taxes | 971.0 | 942.8 |
| Other noncurrent liabilities | 2937.8 | 2862.9 |
| Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred Stock, $0.01 par value, 15,000,000 shares authorized, none issued and outstanding as of June 30, 2025 and December 31, 2024 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common Stock, $0.01 par value, 1,000,000,000 shares authorized, 391,351,508 shares issued and 317,407,176 shares outstanding as of September 30, 2025, 394,648,654 shares issued and 316,932,047 shares outstanding as of December 31, 2024 | 3.2 | 3.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital in excess of par value | 22.7 | 2.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 14845.4 | 13926.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (2090.6) | (2449.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Mosaic stockholders' equity | 12780.7 | 11482.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncontrolling interests | 156.3 | 132.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity | 12937.0 | 11614.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and equity | $24667.5 | $22924.0 |

---

------

**Condensed Consolidated Statements of Cash Flows**

**(in millions, except per share amounts)**

---

| | |
|:---|:---|
| **The Mosaic Company** | **(unaudited)** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Nine months ended** | **Nine months ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Cash Flows from Operating Activities:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net earnings including noncontrolling interests | $424.1 | $130.7 | $1093.8 | $36.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net earnings including noncontrolling interests to net cash provided by operating activities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation, depletion and amortization | 277.0 | 237.9 | 781.7 | 743.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred and other income taxes | 31.1 | (3.6) | 55.7 | 36.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity in net (earnings) of nonconsolidated companies, net of dividends | (0.8) | (4.5) | (1.8) | (49.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accretion expense for asset retirement obligations | 32.7 | 26.8 | 97.5 | 80.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation expense | 6.5 | 5.5 | 24.2 | 26.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized (gain) loss on equity securities | (308.0) |  | (407.7) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized (gain) loss on derivatives | 27.2 | (38.7) | (85.1) | 22.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency adjustments | 65.1 | (232.0) | (285.9) | 117.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt financing fees | 10.5 | 3.5 | 33.6 | 25.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment of assets held for sale | 73.0 |  | 73.0 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 21.1 | 4.1 | 100.8 | 50.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables, net | 57.3 | 273.6 | 71.9 | 195.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (200.8) | (347.5) | (578.9) | (517.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current and noncurrent assets | 3.7 | (117.5) | 27.6 | (179.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | (287.8) | 219.3 | (169.1) | 257.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other noncurrent liabilities | (3.4) | 155.3 | 49.6 | 233.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 228.5 | 312.9 | 880.9 | 1079.9 |
| **Cash Flows from Investing Activities:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (364.4) | (240.8) | (1009.8) | (957.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of available-for-sale securities - restricted | (100.6) | (430.9) | (598.2) | (1162.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of available-for-sale securities - restricted | 100.5 | 421.1 | 577.9 | 1119.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 1.6 | 2.9 | 7.9 | 16.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (362.9) | (247.7) | (1022.2) | (984.5) |
| **Cash Flows from Financing Activities:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Short-term debt, net | 213.9 | 170.3 | 205.4 | 151.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventory financing arrangement, net | (101.7) | (302.1) | 101.2 | 200.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Structured accounts payable arrangements, net | (5.2) | 129.6 | (15.9) | (12.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transferred receivables, net | (3.2) | 1.4 |  | 1.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term debt, net | (14.9) | (12.7) | (49.8) | (55.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repurchases of stock |  | (50.0) |  | (210.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash dividends paid | (69.5) | (66.8) | (210.5) | (204.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends paid to non-controlling interest | (6.7) | (5.8) | (13.1) | (17.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | (8.9) | (1.8) | (26.7) | (22.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | 3.8 | (137.9) | (9.4) | (168.6) |
| Effect of exchange rate changes on cash | 5.5 | 54.5 | 23.0 | 44.5 |
| Net change in cash, cash equivalents and restricted cash | (125.1) | (18.2) | (127.7) | (28.7) |
| Cash, cash equivalents and restricted cash - beginning of period | 302.4 | 350.3 | 305.0 | 360.8 |
| Cash, cash equivalents and restricted cash - end of period | $177.3 | $332.1 | $177.3 | $332.1 |

---

------

**Condensed Consolidated Statements of Cash Flows (Continued)**

**(in millions, except per share amounts)**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended** | **Nine Months Ended** |
| | **September 30, 2025** | **September 30, 2024** |
| **Reconciliation of cash, cash equivalents and restricted cash reported within the unaudited condensed consolidated balance sheets to the unaudited statements of cash flows:** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $153.3 | $301.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted cash in other current assets | 8.0 | 15.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted cash in other assets | 16.0 | 15.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cash, cash equivalents and restricted cash shown in the unaudited statements of cash flows | $177.3 | $332.1 |

---

**<u>Reconciliation of Non-GAAP Financial Measures</u>**

**<u>Earnings Per Share Calculation</u>**

---

| | | |
|:---|:---|:---|
| | **Three months ended September 30,** | **Three months ended September 30,** |
| | **2025** | **2024** |
| Net income (loss) attributable to Mosaic | $411.4 | $122.2 |
| Basic weighted average number of shares outstanding | 317.4 | 318.4 |
| Dilutive impact of share-based awards | 2.0 | 1.0 |
| Diluted weighted average number of shares outstanding | 319.4 | 319.4 |
| Basic net income (loss) per share attributable to Mosaic | $1.30 | $0.38 |
| Diluted net income (loss) per share attributable to Mosaic | $1.29 | $0.38 |
| Notable items impact on net income (loss) per share attributable to Mosaic | 0.25 | 0.04 |
| Adjusted diluted net income (loss) per share attributable to Mosaic | $1.04 | $0.34 |

---

**<u>Free Cash Flow</u>**

---

| | | |
|:---|:---|:---|
| | **Three months ended September 30,** | **Three months ended September 30,** |
| | **2025** | **2024** |
| Net cash provided by operating activities | $229 | $313 |
| Capital expenditures | (364) | (241) |
| Free cash flow | $(135) | $72 |

---

------

**<u>Reconciliation of Non-GAAP Financial Measures</u>**

---

| | | | |
|:---|:---|:---|:---|
| **Consolidated Earnings *(in millions)*** | **Three months ended** | **Three months ended** | **Three months ended** |
| | **September 30,** | **June 30,** | **September 30,** |
|  | **2025** | **2025** | **2024** |
| Consolidated net earnings (loss) attributable to Mosaic | $411 | $411 | $122 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Consolidated interest expense, net | (46) | (53) | (42) |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Consolidated depreciation, depletion and amortization | 277 | 262 | 238 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Accretion expense | 33 | 33 | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Share-based compensation expense | 7 | 8 | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Consolidated provision for income taxes | 175 | 146 | 48 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Equity in net earnings of nonconsolidated companies, net of dividends |  |  | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Notable items | (143) | (347) | (28) |
| Adjusted EBITDA | $806 | $566 | $448 |

---

---

| | |
|:---|:---|
| **Income Tax Effective Tax Rate *(in millions)*** | **Three months ended <br>September 30,** |
|  | **2025** |
| Income Tax Expense | $175 |
| Earnings Before Tax | $599 |
| Effective Tax Rate | 29.3% |
| Income Tax Expense | $175 |
| Tax Allowance Reversal | (5) |
| Tax Expense on All Other Notable Items (see notable items table for details of these items) | (50) |
| Adjusted Income Tax Expense | $120 |
| Earnings Before Tax | $599 |
| Earnings Impact of All Notable Items (net of non-controlling interest) | (135) |
| Adjusted Earnings Before Tax | $464 |
| Adjusted Effective Tax Rate | 25.9% |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| | **September 30,** | **June 30,** | **September 30,** |
| **Potash Earnings *(in millions)*** | **2025** | **2025** | **2024** |
| Operating Earnings | $229 | $194 | $109 |
| &nbsp;&nbsp;&nbsp;Plus: Depreciation, Depletion and Amortization | 93 | 79 | 69 |
| &nbsp;&nbsp;&nbsp;Plus: Accretion Expense | 3 | 3 | 2 |
| &nbsp;&nbsp;&nbsp;Plus: Foreign Exchange Gain (Loss) | (56) | 82 | 48 |
| &nbsp;&nbsp;&nbsp;Plus: Other Income (Expense) | 3 | 1 |  |
| &nbsp;&nbsp;&nbsp;Plus: Notable Items | 57 | (81) | (48) |
| Adjusted EBITDA | $329 | $278 | $180 |

---

------

**<u>Reconciliation of Non-GAAP Financial Measures</u>**

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| | **September 30,** | **June 30,** | **September 30,** |
| **Phosphate Earnings *(in millions)*** | **2025** | **2025** | **2024** |
| Operating Earnings (Loss) | $102 | $(8) | $8 |
| &nbsp;&nbsp;&nbsp;Plus: Depreciation, Depletion and Amortization | 129 | 129 | 118 |
| &nbsp;&nbsp;&nbsp;Plus: Accretion Expense | 26 | 26 | 20 |
| &nbsp;&nbsp;&nbsp;Plus: Foreign Exchange Gain (Loss) | 10 | (7) | (5) |
| &nbsp;&nbsp;&nbsp;Plus: Other Income (Expense) | (4) | (8) | 1 |
| &nbsp;&nbsp;&nbsp;Less: Earnings from Consolidated Noncontrolling Interests | 11 | 10 | 8 |
| &nbsp;&nbsp;&nbsp;Plus: Notable Items | 28 | 95 | 131 |
| Adjusted EBITDA | $280 | $217 | $265 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| | **September 30,** | **June 30,** | **September 30,** |
| **Mosaic Fertilizantes Earnings *(in millions)*** | **2025** | **2025** | **2024** |
| Operating Earnings | $96 | $109 | $56 |
| &nbsp;&nbsp;&nbsp;Plus: Depreciation, Depletion and Amortization | 46 | 44 | 39 |
| &nbsp;&nbsp;&nbsp;Plus: Accretion Expense | 4 | 4 | 4 |
| &nbsp;&nbsp;&nbsp;Plus: Foreign Exchange Gain (Loss) | (19) | (17) | 17 |
| &nbsp;&nbsp;&nbsp;Plus: Other Income (Expense) | (1) | (1) | (2) |
| &nbsp;&nbsp;&nbsp;Less: Earnings (Loss) from Consolidated Noncontrolling Interests | 1 | (1) |  |
| &nbsp;&nbsp;&nbsp;Plus: Notable Items | 116 | 19 | (31) |
| Adjusted EBITDA | $241 | $159 | $83 |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| | **September 30,** | **June 30,** | **September 30,** |
| **Corporate and Other Earnings *(in millions)*** | **2025** | **2025** | **2024** |
| Operating Earnings (Loss) | $(88) | $(51) | $(58) |
| &nbsp;&nbsp;&nbsp;Plus: Depreciation, Depletion and Amortization | 9 | 10 | 12 |
| &nbsp;&nbsp;&nbsp;Plus: Accretion Expense | 7 | 7 | 5 |
| &nbsp;&nbsp;&nbsp;Plus: Foreign Exchange Gain (Loss) | 64 | 111 | 40 |
| &nbsp;&nbsp;&nbsp;Plus: Other Income (Expense) | 308 | 213 |  |
| &nbsp;&nbsp;&nbsp;Plus: Earnings (Loss) from Equity Investments |  | 2 |  |
| &nbsp;&nbsp;&nbsp;Less: Earnings from Consolidated Noncontrolling Interests |  |  | (1) |
| &nbsp;&nbsp;&nbsp;Plus: Notable Items | (344) | (380) | (80) |
| Adjusted EBITDA | $(44) | $(88) | $(80) |

---

------

**<u>Reconciliation of Non-GAAP Financial Measures</u>**

---

| | | | |
|:---|:---|:---|:---|
| | **Three months ended** | **Three months ended** | **Three months ended** |
| | **September 30,** | **June 30,** | **September 30,** |
| | **2025** | **2025** | **2024** |
| **Potash** |  |  |  |
| Total COGS | $459 | $501 | $404 |
| &nbsp;&nbsp;&nbsp;Depreciation & accretion expense | 96 | 82 | 71 |
| &nbsp;&nbsp;&nbsp;Canadian Resource Taxes | 87 | 62 | 44 |
| &nbsp;&nbsp;&nbsp;Change in Inventory | (13) | 26 | (10) |
| &nbsp;&nbsp;&nbsp;Non-MOP Production Costs | 134 | 179 | 167 |
| Total MOP Cash Costs | $155 | $152 | $132 |
| &nbsp;&nbsp;&nbsp;Production tonnes (thousands) | 2186 | 2025 | 1789 |
| **MOP Cash Costs of Production per production tonne** | $**71** | $**75** | $**74** |
| **Phosphate** |  |  |  |
| Total COGS | $1146 | $1070 | $863 |
| &nbsp;&nbsp;&nbsp;Depreciation & accretion expense | 161 | 163 | 139 |
| &nbsp;&nbsp;&nbsp;Miski Mayo costs | 55 | 22 | 48 |
| &nbsp;&nbsp;&nbsp;Change in Inventory | 310 | 226 | 218 |
| &nbsp;&nbsp;&nbsp;Non Production Costs | 267 | 334 | 170 |
| &nbsp;&nbsp;&nbsp;Cash cost of U.S. Mined Rock | 133 | 135 | 124 |
| U.S. Rock Production tonnes (thousands) | 2158 | 2657 | 2199 |
| **Cash costs of U.S. mined rock/production tonne** | $**62** | $**51** | $**56** |
| Phosphate cash costs of conversion | $220 | $190 | $164 |
| Production tonnes (thousands) | 1677 | 1505 | 1625 |
| **Phosphate cash costs of conversion per production tonne** | $**131** | $**126** | $**101** |
| **Fertilizantes** |  |  |  |
| Total COGS | $1410 | $1013 | $1271 |
| &nbsp;&nbsp;&nbsp;Distribution product costs | 1202 | 810 | 937 |
| &nbsp;&nbsp;&nbsp;Depreciation & accretion expense | 51 | 48 | 39 |
| &nbsp;&nbsp;&nbsp;Change in Inventory | (139) | (93) | 25 |
| &nbsp;&nbsp;&nbsp;Non Production Costs | 87 | 65 | 71 |
| &nbsp;&nbsp;&nbsp;Rock cash costs of production | 101 | 90 | 112 |
| Potash cash costs of production | 25 | 22 | 18 |
| &nbsp;&nbsp;&nbsp;Production tonnes (thousands) | 104 | 122 | 105 |
| **Potash cash costs of production per production tonne** | $**240** | $**178** | $**175** |
| Phosphate cash costs of conversion | $83 | $71 | $68 |
| &nbsp;&nbsp;&nbsp;Production tonnes (thousands) | 835 | 842 | 779 |
| **Phosphate cash costs of conversion per production tonne** | $**99** | $**84** | $**88** |

---

## Exhibit 99.2

**Exhibit 99.2**

**The Mosaic Company**

**Selected Calendar Quarter Financial Information**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Q4 2023** | **Q1 2024** | **Q2 2024** | **Q3 2024** | **Q4 2024** | **Q1 2025** | **Q2 2025** | **Q3 2025** |
| **Consolidated data** *(in millions, except per share)* | | | | | | | | |
| &nbsp;&nbsp;&nbsp;**Diluted net earnings (loss) per share** | $**1.11** | $**0.14** | $**(0.50)** | $**0.38** | $**0.53** | $**0.75** | $**1.29** | $**1.29** |
| &nbsp;&nbsp;&nbsp;Notable items impact on earnings per share<sup>(a)</sup> | 0.40 | (0.51) | (1.04) | 0.04 | 0.08 | 0.26 | 0.78 | 0.25 |
| &nbsp;&nbsp;&nbsp;Adjusted diluted net earnings per share<sup>(a)</sup> | $0.71 | $0.65 | $0.54 | $0.34 | $0.45 | $0.49 | $0.51 | $1.04 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted weighted average # of shares outstanding | 327.7 | 323.5 | 321.2 | 319.4 | 318.5 | 318.2 | 319.0 | 319.4 |
| &nbsp;&nbsp;&nbsp;**Total Net Sales** | $**3149** | $**2679** | $**2817** | $**2811** | $**2816** | $**2621** | $**3005** | $**3452** |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of goods sold | 2589 | 2280 | 2423 | 2395 | 2514 | 2133 | 2487 | 2900 |
| &nbsp;&nbsp;&nbsp;**Gross Margin** | $**560** | $**399** | $**394** | $**416** | $**302** | $**488** | $**518** | $**552** |
| &nbsp;&nbsp;&nbsp;&nbsp;SG&A | 123 | 107 | 128 | 149 | 113 | 123 | 167 | 126 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other operating (income) expense | 158 | 119 | 33 | 153 | 89 | 27 | 107 | 87 |
| &nbsp;&nbsp;&nbsp;**Operating earnings** | $**279** | $**173** | $**233** | $**115** | $**100** | $**338** | $**244** | $**339** |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | (35) | (48) | (46) | (42) | (47) | (41) | (53) | (46) |
| &nbsp;&nbsp;&nbsp;&nbsp;Consolidated foreign currency gain/(loss) | 91 | (100) | (268) | 101 | (419) | 133 | 169 | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Earnings from consolidated companies before income taxes | **324** | **25** | **(74)** | **174** | **191** | **313** | **564** | **599** |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for (benefit from) income taxes | (44) | 6 | 99 | 48 | 34 | 63 | 146 | 175 |
| &nbsp;&nbsp;&nbsp;**Earnings (loss) from consolidated companies** | $**368** | $**19** | $**(173)** | $**126** | $**157** | $**250** | $**418** | $**424** |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity in net earnings (loss) of nonconsolidated companies |  | 37 | 22 | 5 | 9 |  | 2 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Net earnings (loss) attributable to noncontrolling interests | 3 | 11 | 11 | 9 | (3) | 12 | 9 | 13 |
| &nbsp;&nbsp;&nbsp;**Net earnings (loss) attributable to Mosaic** | $**365** | $**45** | $**(162)** | $**122** | $**169** | $**238** | $**411** | $**411** |
| &nbsp;&nbsp;&nbsp;&nbsp;After tax Notable items included in earnings | $131 | $(165) | $(334) | $15 | $25 | $82 | $249 | $100 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Margin Rate | *18 %* | *15 %* | *14 %* | *15 %* | *11 %* | *19 %* | *17 %* | *16 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;Effective Tax Rate (including discrete tax) | *(14) %* | *24 %* | *(133) %* | *28 %* | *18 %* | *20 %* | *26 %* | *29 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;Discrete Tax benefit (expense) | $2 | $1 | $(120) | $4 | $(11) | $26 | $(1) | $(2) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation, Depletion and Amortization | $257 | $241 | $264 | $238 | $283 | $243 | $262 | $277 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accretion Expense | $27 | $27 | $28 | $26 | $31 | $32 | $33 | $33 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-Based Compensation Expense | $6 | $9 | $12 | $5 | $7 | $10 | $7 | $7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notable Items | $— | $222 | $319 | $(28) | $32 | $(83) | $(347) | $(143) |
| &nbsp;&nbsp;**Adjusted EBITDA**<sup>(b)</sup> | $**646** | $**576** | $**584** | $**448** | $**594** | $**544** | $**566** | $**806** |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) operating activities | $538 | $(80) | $847 | $313 | $219 | $43 | $610 | $229 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest (net of amount capitalized) | 76 | 17 | 77 | 20 | 72 | 12 | 82 | 20 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash paid for income taxes (net of refunds) | (36) | 99 | 74 | 111 | 53 | 76 | 75 | 89 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | $(362) | $(388) | $(349) | $(248) | $(277) | $(341) | $(319) | $(363) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (359) | (383) | (334) | (241) | (294) | (341) | (305) | (364) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash (used in) provided by financing activities | $(411) | $458 | $(489) | $(138) | $37 | $272 | $(285) | $4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash dividends paid | (65) | (70) | (68) | (67) | (67) | (71) | (70) | (70) |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of exchange rate changes on cash | $(6) | $(4) | $(6) | $55 | $(7) | $— | $18 | $6 |
| &nbsp;&nbsp;&nbsp;**Net change in cash and cash equivalents** | $**(241)** | $**(14)** | $**3** | $**(18)** | $**(27)** | $**(26)** | $**24** | $**(125)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Short-term debt | $400 | $1204 | $882 | $752 | $847 | $1234 | $1041 | $1154 |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt (including current portion) | 3362 | 3350 | 3319 | 3313 | 3378 | 3363 | 3370 | 3415 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash & cash equivalents | 349 | 337 | 322 | 302 | 273 | 259 | 286 | 153 |
| &nbsp;&nbsp;&nbsp;**Net debt** | $**3413** | $**4217** | $**3879** | $**3763** | $**3952** | $**4338** | $**4125** | $**4416** |
| **Segment Contributions** *(in millions)* |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phosphate | $1070 | $1169 | $1180 | $1005 | $1165 | $1099 | $1173 | $1290 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Potash | 758 | 643 | 663 | 526 | 557 | 570 | 710 | 695 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mosaic Fertilizantes | 1192 | 886 | 1049 | 1399 | 1088 | 934 | 1175 | 1592 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate and Other<sup>(c)</sup> | 129 | (19) | (75) | (119) | 6 | 18 | (53) | (125) |
| &nbsp;&nbsp;&nbsp;**Total net sales** | $**3149** | $**2679** | $**2817** | $**2811** | $**2816** | $**2621** | $**3005** | $**3452** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phosphate | $21 | $40 | $133 | $8 | $44 | $139 | $(8) | $102 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Potash | 222 | 198 | 174 | 109 | 123 | 157 | 194 | 229 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mosaic Fertilizantes | 50 | 42 | 61 | 56 | 79 | 98 | 109 | 96 |
| &nbsp;&nbsp;&nbsp;&nbsp;Corporate and Other<sup>(c)</sup> | (14) | (107) | (135) | (58) | (146) | (56) | (51) | (88) |
| &nbsp;&nbsp;&nbsp;**Consolidated operating earnings** | $**279** | $**173** | $**233** | $**115** | $**100** | $**338** | $**244** | $**339** |

---

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;Phosphate<sup>(d)</sup> | 1582 | 1644 | 1696 | 1475 | 1622 | 1498 | 1546 | 1571 |
| &nbsp;&nbsp;&nbsp;&nbsp;Potash<sup>(d)</sup> | 2577 | 2163 | 2346 | 1996 | 2239 | 2113 | 2343 | 2279 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mosaic Fertilizantes | 2158 | 1715 | 2196 | 2879 | 2240 | 1847 | 2232 | 2803 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Corporate and Other | 618 | 333 | 316 | 297 | 432 | 361 | 301 | 232 |
| &nbsp;&nbsp;**Total finished product tonnes sold** *('000 tonnes)* | **6935** | **5855** | **6554** | **6647** | **6533** | **5819** | **6422** | **6885** |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales of Performance Products ('000 tonnes)<sup>(e)</sup> | 1044 | 787 | 839 | 1001 | 1135 | 681 | 900 | 996 |

---

------

**The Mosaic Company - Phosphate Segment**

**Selected Calendar Quarter Financial Information**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Q4 2023** | **Q1 2024** | **Q2 2024** | **Q3 2024** | **Q4 2024** | **Q1 2025** | **Q2 2025** | **Q3 2025** |
| **Net Sales and Gross Margin** *(in millions, except per tonne)* | | | | | | | | |
| &nbsp;&nbsp;&nbsp;**Segment income statement** | | | | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Sales - Finished Goods |  |  |  |  |  | $946 | $1028 | $1118 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Sales - Other revenue |  |  |  |  |  | 153 | 145 | 172 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net Sales** | $**1070** | $**1169** | $**1180** | $**1005** | $**1165** | $**1099** | $**1173** | $**1290** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of Goods Sold | 931 | 1010 | 1026 | 863 | 1027 | 932 | 1070 | 1146 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Gross Margin** | $**139** | $**159** | $**154** | $**142** | $**138** | $**167** | $**103** | $**144** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notable Items Included in Gross Margin | (28) |  | (15) |  | (53) |  |  | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Adjusted Gross Margin**<sup>(b)</sup> | $**167** | $**159** | $**169** | $**142** | $**191** | $**167** | $**103** | $**158** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SG&A | 11 | 13 | 10 | 12 | 10 | 12 | 13 | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating (income) expense | 107 | 106 | 11 | 123 | 84 | 16 | 98 | 32 |
| &nbsp;&nbsp;&nbsp;**Operating Earnings** | $**21** | $**40** | $**133** | $**8** | $**44** | $**139** | $**(8)** | $**102** |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Depreciation, Depletion and Amortization | 124 | 117 | 128 | 118 | 143 | 113 | 129 | 129 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Accretion Expense | 19 | 20 | 20 | 20 | 25 | 25 | 26 | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Foreign Exchange Gain (Loss) | (1) | 2 | 2 | (5) | (4) | (3) | (7) | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Other Income (Expense) | (9) | 3 | (2) | 1 | 517 |  | (8) | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Dividends from equity investments |  | 15 |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Earnings (loss) from Consolidated Noncontrolling Interests | 2 | 10 | 11 | 8 | (4) | 8 | 10 | 11 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Notables Items | 107 | 90 | 38 | 131 | (388) | 10 | 95 | 28 |
| &nbsp;&nbsp;**Adjusted EBITDA**<sup>(b)</sup> | $**259** | $**277** | $**308** | $**265** | $**341** | $**276** | $**217** | $**280** |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | $208 | $197 | $177 | $127 | $160 | $236 | $185 | $221 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Margin $/ tonne of finished product | $88 | $97 | $91 | $96 | $85 | $111 | $67 | $92 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted Gross Margin $/ tonne of finished product | $106 | $97 | $100 | $96 | $118 | $111 | $67 | $101 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross margin as a percent of sales | *13 %* | *14 %* | *13 %* | *14 %* | *12 %* | *15 %* | *9 %* | *11 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;Freight included in finished goods COGS | $105 | $103 | $104 | $79 | $83 | $84 | $93 | $97 |
| &nbsp;&nbsp;&nbsp;&nbsp;Idle/Turnaround costs (excluding notable items) | $32 | $56 | $36 | $7 | $24 | $44 | $84 | $42 |
| **Operating Data** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;**Sales volumes** *('000 tonnes)*<sup>(d)</sup> |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DAP/MAP | 762 | 900 | 828 | 656 | 749 | 846 | 711 | 760 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performance & other products<sup>(f)</sup> | 741 | 673 | 794 | 750 | 814 | 587 | 773 | 750 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other products<sup>(i)</sup> | 79 | 71 | 74 | 69 | 59 | 65 | 62 | 61 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Finished Product**<sup>(d)</sup> | **1582** | **1644** | **1696** | **1475** | **1622** | **1498** | **1546** | **1571** |
| &nbsp;&nbsp;&nbsp;DAP selling price (fob plant)<sup>(q)</sup> | $552 | $598 | $575 | $569 | $593 | $623 | $668 | $714 |
| &nbsp;&nbsp;&nbsp;&nbsp;Average finished product selling price(g) | $553 | $593 | $578 | $579 | $606 | $632 | $665 | $712 |
| &nbsp;&nbsp;**Production Volumes** *('000 tonnes)* |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total tonnes produced<sup>(h)</sup> | 1479 | 1577 | 1675 | 1625 | 1413 | 1423 | 1505 | 1678 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating Rate | *60 %* | *64 %* | *68 %* | *66 %* | *58 %* | *58 %* | *61 %* | *68 %* |
| &nbsp;&nbsp;&nbsp;**Raw Materials** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ammonia used in production (tonnes) | $209 | $246 | $243 | $238 | $228 | $214 | $226 | $255 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sulfur used in production | $549 | $725 | $778 | $739 | $694 | $661 | $732 | $772 |
| &nbsp;&nbsp;**Realized costs** *($/tonne)* |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ammonia (tonne)<sup>(j)</sup> | $366 | $404 | $424 | $482 | $435 | $416 | $445 | $455 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sulfur (long ton)<sup>(k)</sup> | $152 | $142 | $138 | $126 | $127 | $157 | $209 | $272 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Blended rock | $77 | $81 | $86 | $87 | $87 | $77 | $74 | $80 |
| &nbsp;&nbsp;&nbsp;Phosphate cash conversion costs, production / tonne<sup>(r)</sup> | $118 | $110 | $100 | $101 | $118 | $134 | $126 | $131 |
| &nbsp;&nbsp;&nbsp;Cash costs of U.S. mined rock/production tonne<sup>(s)</sup> | $56 | $57 | $54 | $56 | $52 | $54 | $51 | $62 |
| &nbsp;&nbsp;&nbsp;&nbsp;ARO cash spending (in millions) | $41 | $40 | $59 | $54 | $72 | $70 | $79 | $60 |

---

------

**The Mosaic Company - Potash Segment**

**Selected Calendar Quarter Financial Information**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Q4 2023** | **Q1 2024** | **Q2 2024** | **Q3 2024** | **Q4 2024** | **Q1 2025** | **Q2 2025** | **Q3 2025** |
| **Net Sales and Gross Margin** *(in millions, except per tonne)* | | | | | | | | |
| &nbsp;&nbsp;&nbsp;**Segment income statement** | | | | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Sales - Finished Goods |  |  |  |  |  | $495 | $641 | $633 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Sales - Other revenue |  |  |  |  |  | 75 | 69 | 62 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net Sales** | $**758** | $**643** | $**663** | $**526** | $**557** | $**570** | $**710** | $**695** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of Goods Sold | 503 | 431 | 477 | 404 | 434 | 402 | 501 | 459 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Gross Margin** | $**255** | $**212** | $**186** | $**122** | $**123** | $**168** | $**209** | $**236** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notable Items Included in Gross Margin |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Adjusted Gross Margin**<sup>(b)</sup> | $**255** | $**212** | $**186** | $**122** | $**123** | $**168** | $**209** | $**236** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SG&A | 8 | 9 | 7 | 7 | 8 | 8 | 8 | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating (income) expense | 25 | 5 | 5 | 6 | (8) | 3 | 7 | 1 |
| &nbsp;&nbsp;&nbsp;**Operating Earnings** | $**222** | $**198** | $**174** | $**109** | $**123** | $**157** | $**194** | $**229** |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Depreciation, Depletion and Amortization | 89 | 82 | 94 | 69 | 93 | 81 | 79 | 93 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Accretion Expense | 3 | 2 | 3 | 2 | 2 | 3 | 3 | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Foreign Exchange Gain (Loss) | 41 | (31) | (12) | 48 | (185) | 13 | 82 | (56) |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Other Income (Expense) | (2) |  |  |  | 1 | (1) | 1 | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Notable Items | (31) | 30 | 12 | (48) | 178 | (13) | (81) | 57 |
| &nbsp;&nbsp;**Adjusted EBITDA**<sup>(b)</sup> | $**322** | $**281** | $**271** | $**180** | $**212** | $**240** | $**278** | $**329** |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | $105 | $97 | $75 | $61 | $65 | $45 | $73 | $72 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Margin $/ tonne of finished product | $99 | $98 | $79 | $61 | $55 | $80 | $89 | $104 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted Gross Margin $/ tonne of finished product | $99 | $98 | $79 | $61 | $55 | $80 | $89 | $104 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross margin as a percent of sales | *34 %* | *33 %* | *28 %* | *23 %* | *22 %* | *29 %* | *29 %* | *34 %* |
| &nbsp;&nbsp;&nbsp;**Supplemental Cost Information** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Canadian resource taxes | $102 | $64 | $67 | $45 | $56 | $47 | $62 | $87 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Royalties | $13 | $10 | $10 | $9 | $10 | $9 | $10 | $12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Freight expense<sup>(l)</sup> | $78 | $86 | $94 | $87 | $60 | $74 | $74 | $66 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Idle/Turnaround costs (excluding notable items) | $3 | $9 | $18 | $23 | $6 | $1 | $34 | $16 |
| **Operating Data** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;**Sales volumes** *('000 tonnes)*<sup>(d)</sup> |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MOP | 2359 | 1927 | 2113 | 1775 | 2064 | 1947 | 2122 | 2110 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Performance & other products<sup>(m)</sup> | 207 | 225 | 225 | 211 | 168 | 159 | 214 | 162 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other products<sup>(i)</sup> | 11 | 11 | 8 | 10 | 7 | 7 | 7 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Finished Product**<sup>(d)</sup> | **2577** | **2163** | **2346** | **1996** | **2239** | **2113** | **2343** | **2279** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Crop Nutrients North America | 773 | 838 | 970 | 647 | 779 | 863 | 752 | 649 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Crop Nutrients International | 1666 | 1195 | 1260 | 1255 | 1341 | 1126 | 1439 | 1497 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-Agricultural | 138 | 130 | 116 | 94 | 119 | 124 | 152 | 133 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Finished Product**<sup>(d)</sup> | **2577** | **2163** | **2346** | **1996** | **2239** | **2113** | **2343** | **2279** |
| &nbsp;&nbsp;&nbsp;MOP selling price (fob mine)<sup>(o)</sup> | $243 | $241 | $224 | $215 | $199 | $223 | $261 | $271 |
| &nbsp;&nbsp;&nbsp;&nbsp;Average finished product selling price(g) | $262 | $258 | $240 | $233 | $214 | $234 | $274 | $278 |
| &nbsp;&nbsp;**Production Volumes** *('000 tonnes)* |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Production Volume | 2527 | 2338 | 2224 | 1904 | 2332 | 2256 | 2094 | 2258 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating Rate | *90 %* | *81 %* | *78 %* | *66 %* | *81 %* | *78 %* | *73 %* | *79 %* |
| &nbsp;&nbsp;&nbsp;MOP cash costs of production including brine / production tonne<sup>(n)</sup> | $66 | $72 | $64 | $74 | $73 | $78 | $75 | $71 |
| &nbsp;&nbsp;&nbsp;&nbsp;ARO cash spending (in millions) | $2 | $1 | $2 | $2 | $3 | $1 | $3 | $2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Average CAD / USD | $1.361 | $1.348 | $1.368 | $1.364 | $1.399 | $1.434 | $1.384 | $1.377 |

---

------

**The Mosaic Company - Mosaic Fertilizantes Segment**

**Selected Calendar Quarter Financial Information**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Q4 2023** | **Q1 2024** | **Q2 2024** | **Q3 2024** | **Q4 2024** | **Q1 2025** | **Q2 2025** | **Q3 2025** |
| **Net Sales and Gross Margin** *(in millions, except per tonne)* | | | | | | | | |
| &nbsp;&nbsp;&nbsp;**Segment income statement** | | | | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Sales - Finished Goods |  |  |  |  |  | $834 | $1059 | $1452 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net Sales - Other revenue |  |  |  |  |  | 100 | 116 | 140 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net Sales** | $**1192** | $**886** | $**1049** | $**1399** | $**1088** | $**934** | $**1175** | $**1592** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of Goods Sold | 1098 | 811 | 947 | 1271 | 986 | 807 | 1013 | 1410 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Gross Margin** | $**94** | $**75** | $**102** | $**128** | $**102** | $**127** | $**162** | $**182** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notable Items Included in Gross Margin | (3) | 1 | 4 | 6 | 9 |  |  | (7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Adjusted Gross Margin**<sup>(b)</sup> | $**97** | $**74** | $**98** | $**122** | $**93** | $**127** | $**162** | $**189** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SG&A | 29 | 30 | 27 | 62 | 16 | 23 | 61 | 32 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating (income) expense | 15 | 3 | 14 | 10 | 7 | 6 | (8) | 54 |
| &nbsp;&nbsp;&nbsp;**Operating Earnings** | $**50** | $**42** | $**61** | $**56** | $**79** | $**98** | $**109** | $**96** |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Depreciation, Depletion and Amortization | 41 | 40 | 40 | 39 | 40 | 38 | 44 | 46 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Accretion Expense | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Foreign Exchange Gain (Loss) | 32 | (45) | (144) | 17 | (84) | 41 | (17) | (19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Other Income (Expense) | (1) | (2) | (2) | (2) | (2) | (1) | (1) | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Earnings from Consolidated Noncontrolling Interests |  | 1 | (1) |  | 1 | 1 | (1) | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Notable Items | (16) | 44 | 135 | (31) | 46 | (57) | 19 | 116 |
| &nbsp;&nbsp;**Adjusted EBITDA**<sup>(b)</sup> | $**111** | $**83** | $**96** | $**83** | $**82** | $**122** | $**159** | $**241** |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | $68 | $82 | $46 | $51 | $64 | $59 | $46 | $70 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Margin $/ tonne of finished product | $44 | $44 | $46 | $44 | $46 | $69 | $73 | $65 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted Gross Margin $/ tonne of finished product | $45 | $43 | $45 | $42 | $42 | $69 | $73 | $67 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross margin as a percent of sales | *8 %* | *8 %* | *10 %* | *9 %* | *9 %* | *14 %* | *14 %* | *11 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;Idle/Turnaround costs (excluding notable items) | $26 | $15 | $24 | $40 | $18 | $13 | $26 | $27 |
| **Operating Data** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;**Sales volumes** *('000 tonnes)* |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fertilizer produced in Brazil sold to third parties | 453 | 357 | 473 | 629 | 461 | 331 | 387 | 363 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fertilizer produced in Brazil sold through distribution | 272 | 328 | 489 | 409 | 207 | 358 | 666 | 685 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchased nutrients for distribution(p) | 1433 | 1030 | 1234 | 1841 | 1572 | 1158 | 1179 | 1755 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total Finished Product** | **2158** | **1715** | **2196** | **2879** | **2240** | **1847** | **2232** | **2803** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sales of Performance Products ('000 tonnes)<sup>(e)</sup> | 341 | 123 | 215 | 462 | 307 | 93 | 252 | 441 |
| &nbsp;&nbsp;&nbsp;&nbsp;Brazil MAP price (Brazil production delivered price to third party) | $580 | $581 | $596 | $601 | $632 | $681 | $729 | $738 |
| &nbsp;&nbsp;&nbsp;&nbsp;Average finished product selling price(g) | $500 | $463 | $423 | $447 | $433 | $452 | $474 | $518 |
| &nbsp;&nbsp;**Production Volumes** *('000 tonnes)* |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phosphate tonnes produced | 774 | 793 | 752 | 779 | 781 | 778 | 843 | 834 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MOP tonnes produced | 114 | 104 | 79 | 105 | 108 | 97 | 122 | 104 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phosphate operating rate | *77 %* | *79 %* | *75 %* | *78 %* | *78 %* | *78 %* | *84 %* | *84 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Potash operating rate | *91 %* | *83 %* | *63 %* | *85 %* | *88 %* | *78 %* | *98 %* | *83 %* |
| &nbsp;&nbsp;&nbsp;**Realized Costs ($/tonne)** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ammonia/tonne | $655 | $705 | $623 | $572 | $628 | $684 | $601 | $576 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sulfur (long ton) | $179 | $173 | $174 | $170 | $177 | $219 | $270 | $325 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Blended rock | $117 | $115 | $107 | $105 | $109 | $97 | $94 | $99 |

---

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;**Purchases** *('000 tonnes)* | | | | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DAP/MAP from Mosaic | 58 | 68 | 30 | 43 | 54 | 62 | 21 | 45 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MicroEssentials® from Mosaic | 163 | 169 | 289 | 337 | 195 | 120 | 282 | 270 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Potash from Mosaic/Canpotex | 404 | 358 | 736 | 682 | 419 | 355 | 507 | 919 |
| &nbsp;&nbsp;&nbsp;&nbsp;Phosphate cash conversion costs in USD, production / tonne(r) | $110 | $101 | $100 | $88 | $85 | $87 | $84 | $99 |
| &nbsp;&nbsp;&nbsp;&nbsp;Potash cash conversion costs in USD, production / tonne | $217 | $196 | $208 | $175 | $151 | $187 | $178 | $240 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mined rock costs in USD, cash produced / tonne | $111 | $121 | $98 | $105 | $93 | $87 | $90 | $91 |
| &nbsp;&nbsp;&nbsp;&nbsp;ARO cash spending (in millions) | $7 | $2 | $5 | $6 | $5 | $1 | $1 | $1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Average BRL / USD | $4.953 | $4.952 | $5.216 | $5.546 | $5.842 | $5.853 | $5.669 | $5.445 |

---

------

**The Mosaic Company - Corporate and Other Segment**

**Selected Calendar Quarter Financial Information**

**(Unaudited)**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Q4 2023** | **Q1 2024** | **Q2 2024** | **Q3 2024** | **Q4 2024** | **Q1 2025** | **Q2 2025** | **Q3 2025** |
| **Net Sales and Gross Margin** *(in millions)* | | | | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;**Segment income statement** | | | | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Net Sales** | $**129** | $**(19)** | $**(75)** | $**(119)** | $**6** | $**18** | $**(53)** | $**(125)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of Goods Sold | 57 | 28 | (27) | (143) | 67 | (8) | (97) | (115) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Gross Margin (Loss)** | $**72** | $**(47)** | $**(48)** | $**24** | $**(61)** | $**26** | $**44** | $**(10)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notable items Included in Gross Margin | 40 | (31) | (28) | 38 | (80) | 59 | 51 | (27) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Adjusted Gross Margin (Loss)**<sup>(b)</sup> | $**32** | $**(16)** | $**(20)** | $**(14)** | $**19** | $**(33)** | $**(7)** | $**17** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;SG&A | 75 | 55 | 84 | 68 | 79 | 80 | 85 | 78 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating (income) expense | 11 | 5 | 3 | 14 | 6 | 2 | 10 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Operating Earnings (Loss)** | $**(14)** | $**(107)** | $**(135)** | $**(58)** | $**(146)** | $**(56)** | $**(51)** | $**(88)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plus: Depreciation, Depletion and Amortization | 3 | 2 | 2 | 12 | 7 | 11 | 10 | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plus: Share-Based Compensation Expense | 6 | 9 | 11 | 5 | 7 | 10 | 7 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plus: Foreign Exchange Gain (Loss) | 19 | (27) | (114) | 40 | (145) | 82 | 111 | 64 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plus: Other Income (Expense) |  |  | 11 |  | 39 | (116) | 213 | 308 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plus: Earnings (Loss) from equity investments |  |  |  |  |  |  | 2 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: Earnings (Loss) from Consolidated Noncontrolling Interests |  |  |  | (1) | (1) | 2 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plus: Notable Items | (60) | 58 | 134 | (80) | 196 | (23) | (380) | (344) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Adjusted EBITDA**<sup>(b)</sup> | $**(46)** | $**(65)** | $**(91)** | $**(80)** | $**(41)** | $**(94)** | $**(88)** | $**(44)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Elimination of profit in inventory included in COGS | $16 | $(15) | $(10) | $(3) | $7 | $(49) | $— | $15 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized gain (loss) on derivatives included in COGS | $41 | $(31) | $(29) | $39 | $(80) | $59 | $51 | $27 |

---

------

**The Mosaic Company**

**Selected Calendar Quarter Financial Information**

**(Unaudited)**

**Notable Items**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Q3 2025** | **Q3 2025** | **Q3 2025** | **Q3 2025** | **Q3 2025** | **Q3 2025** |
| **Description** | **Segment** | **Line Item** | **Amount<br>(in millions)** | **Tax Effect**<sup>(t)</sup><br>**(in millions)** | **EPS Impact<br>(per basic share)** |
| Foreign currency transaction gain (loss) | Consolidated | Foreign currency transaction gain (loss) | $(14) | $3 | $(0.04) |
| Unrealized gain (loss) on derivatives | Corporate and Other | Cost of goods sold | (27) | 7 | (0.06) |
| Closed and indefinitely idled facility costs | Phosphate | Other operating income (expense) | (14) | 3 | (0.03) |
| Ma'aden mark-to-market | Corporate and Other | Other non-operating income (expense) | 308 | (80) | 0.71 |
| Environmental Reserve | Phosphate | Other operating income (expense) | (18) | 5 | (0.04) |
| Loss on assets held for sale and transaction fees | Mosaic Fertilizantes/Corporate | Other operating income (expense)/SG&A | (75) |  | (0.23) |
| Asset write-off | Mosaic Fertilizantes | Cost of goods sold/Other operating income (expense) | (11) | 3 | (0.03) |
| Land reclamation | Phosphate | Cost of goods sold | (14) | 4 | (0.03) |
| **Total Notable Items** |  |  | $**135** | $**(55)** | $**0.25** |

---

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Q2 2025** | **Q2 2025** | **Q2 2025** | **Q2 2025** | **Q2 2025** | **Q2 2025** |
| **Description** | **Segment** | **Line Item** | **Amount<br>(in millions)** | **Tax Effect**<sup>(t)</sup><br>**(in millions)** | **EPS Impact<br>(per basic share)** |
| Foreign currency transaction gain (loss) | Consolidated | Foreign currency transaction gain (loss) | $169 | $(45) | $0.39 |
| Unrealized gain (loss) on derivatives | Corporate and Other | Cost of goods sold | 51 | (14) | 0.11 |
| Closed and indefinitely idled facility costs | Phosphate | Other operating income (expense) | $(14) | $4 | $(0.03) |
| Ma'aden mark-to-market | Corporate and Other | Other non-operating income (expense) | 216 | (58) | 0.50 |
| ARO Adjustment | Phosphate | Other operating income (expense) | (44) | 12 | (0.10) |
| Environmental Reserve | Phosphate | Other operating income (expense) | (32) | 9 | (0.07) |
| Realized gain (loss) on RCRA Trust Securities | Phosphate | Other non-operating income (expense) | (7) | 2 | (0.02) |
| **Total Notable Items** |  |  | $**339** | $**(90)** | $**0.78** |
| **Q1 2025** | **Q1 2025** | **Q1 2025** | **Q1 2025** | **Q1 2025** | **Q1 2025** |
| **Description** | **Segment** | **Line Item** | **Amount<br>(in millions)** | **Tax Effect**<sup>(t)</sup><br>**(in millions)** | **EPS Impact<br>(per basic share)** |
| Foreign currency transaction gain (loss) | Consolidated | Foreign currency transaction gain (loss) | $148 | $(43) | $0.33 |
| Unrealized gain (loss) on derivatives | Corporate and Other | Cost of goods sold | 59 | (17) | 0.13 |
| Closed and indefinitely idled facility costs | Phosphate | Other operating income (expense) | (14) | 3 | (0.03) |
| Ma'aden mark-to-market | Corporate and Other | Other non-operating income (expense) | (117) | 34 | (0.26) |
| ARO Adjustment | Phosphate | Other operating income (expense) | (2) | 1 |  |
| Discrete tax items | Consolidated | (Provision for) benefit from income taxes |  | 30 | 0.09 |
| **Total Notable Items** |  |  | $**74** | $**8** | $**0.26** |

---

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Q4 2024** | **Q4 2024** | **Q4 2024** | **Q4 2024** | **Q4 2024** | **Q4 2024** |
| **Description** | **Segment** | **Line Item** | **Amount<br>(in millions)** | **Tax Effect**<sup>(t)</sup><br>**(in millions)** | **EPS Impact<br>(per basic share)** |
| Foreign currency transaction gain (loss) | Consolidated | Foreign currency transaction gain (loss) | $(390) | $75 | $(0.99) |
| Unrealized gain (loss) on derivatives | Corporate and Other | Cost of goods sold | (80) | 15 | (0.20) |
| Closed and indefinitely idled facility costs | Phosphate | Other operating income (expense) | (13) | 2 | (0.04) |
| FX functional currency | Mosaic Fertilizantes | Cost of goods sold | 9 | (2) | 0.02 |
| Realized gain (loss) on RCRA Trust Securities | Phosphate | Other non-operating income (expense) | (5) | 1 | (0.01) |
| ARO Adjustment | Phosphate | Other operating income (expense) | (23) | 4 | (0.06) |
| Hurricane Milton idle costs | Phosphate | Cost of goods sold | (52) | 10 | (0.13) |
| Gain on sale of equity investment | Phosphate | Other non-operating income (expense) | 522 | (43) | 1.51 |
| Ma'aden mark-to-market | Corporate and Other | Other non-operating income (expense) | 28 | (5) | 0.07 |
| ARO Adjustment | Potash | Other operating income (expense) | 7 | (1) | 0.02 |
| Arbitration reserve | Phosphate | Other Operating Expense/Non Controlling Interest | (43) | 9 | (0.11) |
| **Total Notable Items** |  |  | $**(40)** | $**65** | $**0.08** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Q3 2024** | **Q3 2024** | **Q3 2024** | **Q3 2024** | **Q3 2024** | **Q3 2024** |
| **Description** | **Segment** | **Line Item** | **Amount<br>(in millions)** | **Tax Effect**<sup>(t)</sup><br>**(in millions)** | **EPS Impact<br>(per basic share)** |
| Foreign currency transaction gain (loss) | Consolidated | Foreign currency transaction gain (loss) | $111 | $(35) | $0.22 |
| Unrealized gain (loss) on derivatives | Corporate and Other | Cost of goods sold | 38 | (11) | 0.09 |
| Closed and indefinitely idled facility costs | Phosphate | Other operating income (expense) | (15) | 5 | (0.03) |
| FX functional currency | Mosaic Fertilizantes | Cost of goods sold | 6 | (2) | 0.01 |
| Realized gain (loss) on RCRA Trust Securities | Phosphate | Other non-operating income (expense) | 5 | (2) | 0.01 |
| ARO Adjustment | Phosphate | Other operating income (expense) | (102) | 31 | (0.22) |
| Environmental reserve | Phosphate | Other operating income (expense) | (20) | 6 | (0.04) |
| **Total Notable Items** |  |  | $**23** | $**(8)** | $**0.04** |

---

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Q2 2024** | **Q2 2024** | **Q2 2024** | **Q2 2024** | **Q2 2024** | **Q2 2024** |
| **Description** | **Segment** | **Line Item** | **Amount<br>(in millions)** | **Tax Effect**<sup>(t)</sup><br>**(in millions)** | **EPS Impact<br>(per basic share)** |
| Foreign currency transaction gain (loss) | Consolidated | Foreign currency transaction gain (loss) | $(263) | $76 | $(0.58) |
| Unrealized gain (loss) on derivatives | Corporate and Other | Cost of goods sold | (28) | 9 | (0.07) |
| Closed and indefinitely idled facility costs | Phosphate | Other operating income (expense) | (13) | 3 | (0.03) |
| FX functional currency | Mosaic Fertilizantes | Cost of goods sold | 4 | (1) |  |
| Realized gain (loss) on RCRA Trust Securities | Phosphate | Other non-operating income (expense) | (2) |  |  |
| Land reclamation | Phosphate | Cost of goods sold | (15) | 4 | (0.03) |
| Pension plan termination | Corporate and Other | Other non-operating income (expense) | 8 | (2) | 0.02 |
| Franchise tax reversal | Phosphate | Other operating income (expense) | (15) | 4 | (0.03) |
| Discrete tax items | Consolidated | (Provision for) benefit from income taxes |  | (103) | (0.32) |
| **Total Notable Items** |  |  | $**(324)** | $**(10)** | $**(1.04)** |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Q1 2024** | **Q1 2024** | **Q1 2024** | **Q1 2024** | **Q1 2024** | **Q1 2024** |
| **Description** | **Segment** | **Line Item** | **Amount<br>(in millions)** | **Tax Effect**<sup>(t)</sup><br>**(in millions)** | **EPS Impact<br>(per basic share)** |
| Foreign currency transaction gain (loss) | Consolidated | Foreign currency transaction gain (loss) | $(100) | $28 | $(0.22) |
| Unrealized gain (loss) on derivatives | Corporate and Other | Cost of goods sold | (31) | 8 | (0.07) |
| Closed and indefinitely idled facility costs | Phosphate | Other operating income (expense) | (11) | 3 | (0.03) |
| FX functional currency | Mosaic Fertilizantes | Cost of goods sold | 1 |  |  |
| Realized gain (loss) on RCRA Trust Securities | Phosphate | Other non-operating income (expense) | 4 | (1) | 0.01 |
| ARO Adjustment | Phosphate | Other operating income (expense) | (14) | 4 | (0.03) |
| Environmental reserve | Phosphate | Other operating income (expense) | (77) | 21 | (0.17) |
| **Total Notable Items** |  |  | $**(228)** | $**63** | $**(0.51)** |

---

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Q4 2023** | **Q4 2023** | **Q4 2023** | **Q4 2023** | **Q4 2023** | **Q4 2023** |
| **Description** | **Segment** | **Line Item** | **Amount<br>(in millions)** | **Tax Effect**<sup>(t)</sup><br>**(in millions)** | **EPS Impact<br>(per basic share)** |
| Foreign currency transaction gain (loss) | Consolidated | Foreign currency transaction gain (loss) | $79 | $(16) | $0.20 |
| Unrealized gain (loss) on derivatives | Corporate and Other | Cost of goods sold | 40 | (7) | 0.10 |
| Closed and indefinitely idled facility costs | Phosphate | Other operating income (expense) | (9) | 2 | (0.03) |
| FX functional currency | Mosaic Fertilizantes | Cost of goods sold | (3) | 1 | (0.01) |
| Realized gain (loss) on RCRA Trust Securities | Phosphate | Other non-operating income (expense) | (7) | 2 | (0.02) |
| ARO Adjustment | Phosphate | Other operating income (expense) | (4) | 1 | (0.01) |
| Environmental reserve | Phosphate | Other operating income (expense) | (64) | 11 | (0.16) |
| Land reclamation | Phosphate | Cost of goods sold | (28) | 5 | (0.07) |
| ARO adjustment | Potash | Other operating income (expense) | (10) | 2 | (0.02) |
| Tax law change | Mosaic Fertilizantes | (Provision for) benefit from income taxes |  | 136 | 0.42 |
| **Total Notable Items** |  |  | $**(6)** | $**137** | $**0.40** |

---

------

**Footnotes**

&nbsp;&nbsp;&nbsp;&nbsp;(a)Notable items impact on Earnings Per Share is calculated as notable item amount plus income tax effect, based on expected annual effective tax rate, divided by diluted weighted average shares. Adjusted Diluted Net Earnings per Share is defined as diluted net earnings (loss) per share excluding the impact of notable items. See "Non-GAAP Reconciliations".

&nbsp;&nbsp;&nbsp;&nbsp;(b)See definitions of Adjusted EBITDA and Adjusted Gross Margin under "Non-GAAP Reconciliations".

&nbsp;&nbsp;&nbsp;&nbsp;(c)Includes elimination of intersegment sales.

&nbsp;&nbsp;&nbsp;&nbsp;(d)Finished product sales volumes include intersegment sales.

&nbsp;&nbsp;&nbsp;&nbsp;(e)Includes MicroEssentials, K-Mag, Aspire and Sus-Terra sales tonnes.

&nbsp;&nbsp;&nbsp;&nbsp;(f)Includes MicroEssentials performance products.

&nbsp;&nbsp;&nbsp;&nbsp;(g)Average price of all finished products sold by Potash, Phosphates, Mosaic Fertilizantes and India/China. Amounts prior to January 1, 2025 have been recast to exclude revenue from other non-finished goods.

&nbsp;&nbsp;&nbsp;&nbsp;(h)Includes crop nutrient dry concentrates and animal feed ingredients.

&nbsp;&nbsp;&nbsp;&nbsp;(i)Includes finished goods sales of feed and other products.

&nbsp;&nbsp;&nbsp;&nbsp;(j)Amounts are representative of our average ammonia costs in cost of goods sold.

&nbsp;&nbsp;&nbsp;&nbsp;(k)Amounts are representative of our average sulfur costs in cost of goods sold.

&nbsp;&nbsp;&nbsp;&nbsp;(l)Includes inbound freight, outbound freight and warehousing costs on K-Mag, animal feed and domestic MOP sales.

&nbsp;&nbsp;&nbsp;&nbsp;(m)Includes K-Mag, and Aspire finished performance products.

&nbsp;&nbsp;&nbsp;&nbsp;(n)MOP cash costs of production are reflective of actual costs during the period excluding brine management costs, depreciation, depletion, accretion, carbon-based and Canadian resource tax, idle and turnaround costs. Total Production costs for MOP production excludes K-Mag costs, Aspire raw material costs and incremental Aspire operating costs.

&nbsp;&nbsp;&nbsp;&nbsp;(o)Excludes industrial and feed sales. Price has been calculated using the average monthly foreign exchange rate.

&nbsp;&nbsp;&nbsp;&nbsp;(p)Includes sales volumes of phosphate and potash nutrients purchased from other Mosaic segments and Canpotex.

&nbsp;&nbsp;&nbsp;&nbsp;(q)Includes intersegment sales.

&nbsp;&nbsp;&nbsp;&nbsp;(r)Total production costs less depreciation, ARO costs including accretion and idle and turnaround costs divided by metric tonnes of finished phosphate production in the period.

&nbsp;&nbsp;&nbsp;&nbsp;(s)Total production cost less depreciation/depletion, ARO costs including accretion and idle and turnaround costs divided by metric tonnes of rock produced in the period.

&nbsp;&nbsp;&nbsp;&nbsp;(t)Tax impact is based on our expected annual effective rate.

------

**The Mosaic Company**

**Selected Calendar Quarter Financial Information**

**(Unaudited)**

**Non-GAAP Financial Measures**

In addition to financial measures prepared in accordance with U.S. generally accepted accounting principles ("GAAP"), Mosaic has presented in this Selected Calendar Quarter Financial Information certain non-GAAP financial measures, or measures calculated based on non-GAAP financial measures, including: Adjusted Diluted Net Earnings Per Share, Consolidated Adjusted EBITDA, Segment Adjusted EBITDA, and Adjusted Gross Margin. Generally, a non-GAAP financial measure is a supplemental numerical measure of a company's performance, financial position or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. Each of the non-GAAP financial measures we present is determined as described below.

The non-GAAP financial measures we present should not be considered as substitutes for, or superior to, measures of financial performance prepared in accordance with GAAP. In addition, because these non-GAAP measures, as presented, are not determined in accordance with GAAP, they are thus susceptible to varying interpretations and calculations and may not be comparable to other similarly titled measures of other companies.

**Adjusted Diluted Net Earnings Per Share**

Adjusted diluted net earnings per share is defined as diluted net earnings per share, excluding the impact of notable items. Notable items impact on diluted net earnings per share is calculated as notable item amount plus income tax effect, based on expected annual effective tax rate, divided by diluted weighted average shares. Management believes that adjusted diluted net earnings per share provides securities analysts, investors and others, in addition to management, with useful supplemental information regarding our performance by excluding certain items that may not be indicative of or are unrelated to our core operating results. Management utilizes adjusted diluted net earnings per share in analyzing and assessing Mosaic's overall performance, for financial and operating decision-making, and to forecast and plan for the future periods. Adjusted diluted net earnings per share also assists our management in comparing our and our competitors' operating results. Reconciliations of adjusted diluted net earnings per share to diluted net earnings per share for the periods presented are provided under "Consolidated Data" on the first page of this Selected Calendar Quarter Financial Information.

**Consolidated Adjusted EBITDA**

Consolidated Adjusted EBITDA is defined as consolidated Net Income (Loss) before net interest expense, depreciation, depletion and amortization, asset retirement obligation accretion, share-based compensation expense and provision for/(benefit from) income taxes less equity in net earnings (loss) of nonconsolidated companies, net of dividends. As of January 1, 2025, we are no longer adjusting for equity in net earnings (loss) of nonconsolidated companies, net of dividends as we sold our equity investment in MWSPC in 2024. Consolidated Adjusted EBITDA is also adjusted for notable items that management excludes in analyzing our performance. Consolidated Adjusted EBITDA is a non-GAAP financial measure that we provide to assist securities analysts, investors, lenders and others in their comparisons of operational performance, valuation and debt capacity across companies with differing capital, tax and legal structures. Consolidated Adjusted EBITDA should not be considered as an alternative to, or more meaningful than, consolidated Net Income (Loss) as a measure of operating performance. A reconciliation of Consolidated Net Income (Loss) to Consolidated Adjusted EBITDA is provided below.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| (*in millions*) | **Q4 2023** | **Q1 2024** | **Q2 2024** | **Q3 2024** | **Q4 2024** | **Q1 2025** | **Q2 2025** | **Q3 2025** |
| Consolidated Net Income (Loss) | $365 | $45 | $(162) | $122 | $169 | $238 | $411 | $411 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Consolidated Interest Expense, Net | (35) | (48) | (46) | (42) | (47) | (41) | (53) | (46) |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Consolidated Depreciation, Depletion & Amortization | 257 | 241 | 264 | 238 | 283 | 243 | 262 | 277 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Accretion Expense | 27 | 27 | 28 | 26 | 31 | 32 | 33 | 33 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Share-Based Compensation Expense (Benefit) | 6 | 9 | 12 | 5 | 7 | 10 | 8 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Consolidated Provision for (Benefit from) Income Taxes | (44) | 6 | 99 | 48 | 34 | 63 | 146 | 175 |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Equity in net earnings (loss) of nonconsolidated companies, net of dividends |  | 22 | 22 | 5 | 9 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Plus: Notable Items |  | 222 | 319 | (28) | 32 | (83) | (347) | (143) |
| Consolidated Adjusted EBITDA | $646 | $576 | $584 | $448 | $594 | $544 | $566 | $806 |

---

------

**Segment Adjusted EBITDA**

Adjusted EBITDA presented at the segment level is defined as the related segment's operating earnings (loss) plus depreciation, depletion and amortization, plus asset retirement obligation accretion, plus foreign exchange gain (loss), plus other income (expense) plus dividends from equity investments, less earnings (loss) from noncontrolling interests. As of January 1, 2025, we are no longer adjusting for equity in net earnings (loss) of nonconsolidated companies, net of dividends as we sold our equity investment in MWSPC in 2024 that represented nearly all of these historical earnings. Adjusted EBITDA is also adjusted for notable items that management excludes in analyzing our performance. We provide these non-GAAP financial measures because we believe they are relevant and useful to securities analysts, investors and others because they are part of our internal management reporting and planning process, and our management uses these measures to evaluate the operational performance and valuation of our segments. Management also uses these measures as a method of comparing segment, performance with that of its competitors. Segment Adjusted EBITDA should not be considered as alternatives to, or more meaningful than, segment Operating Earnings (Loss) and segment Operating Earnings (Loss)/sales tonne, respectively, as measures of operating performance. Management believes Operating Earnings (Loss) and segment Operating Earnings (Loss)/sales tonne, respectively, are the most directly comparable GAAP measures because we do not allocate taxes on a segment basis. Reconciliations of Segment Adjusted EBITDA to segment Operating Earnings (Loss) and segment Operating (Loss) Earnings/sales tonne, respectively, are provided as part of each segment's Selected Calendar Quarter Financial Information.

**Adjusted Gross Margin**

Adjusted gross margin is defined as gross margin excluding the impact of notable items. Management believes the adjusted measures provides security analysts, investors, management & others with useful supplemental information regarding our performance by excluding certain items that may not be indicative of, or are unrelated to, our core operating results. Management utilizes adjusted gross margin in analyzing and assessing Mosaic's overall performance for financial and operating decision-making and to forecast and plan for future periods.

<br>